オキサゾラム

Oxazolam

HCID 4617CAS 24143-17-7

基本情報

標準SMILES
CC1CN2CC(=O)Nc3ccc(Cl)cc3C2(c2ccccc2)O1
InChIKey
VCCZBYPHZRWKFY-UHFFFAOYSA-N
分子式
C18H17ClN2O2
平均分子量
328.8 g/mol
単同位体質量
328.0978555

名称と識別子

優先名称
Oxazolam
IUPAC
10-chloro-2-methyl-11b-phenyl-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one
現地名
オキサゾラム
英語名
OXAZOLAM METHANOL SOLUTION
分子式
C18H17ClN2O2
分子量
328.79

名称と別名

oxazolamOxazolazepamTranquitHializan24143-17-7Oxazolamum1V2WI2NA1CDTXSID502340110-Chloro-2-methyl-11b-phenyl-2,3,7,11b-tetrahydro(1,3)oxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one10-Chloro-2-methyl-11b-phenyl-2,3,7,11b-tetrahydro[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6(5H)-oneRefChem:857082DTXCID80209312
名称をさらに表示
ネブスンオキサゾラム10-クロロ-2,3,7,11b-テトラヒドロ-2-メチル-11b-フェニルオキサゾロ[3,2-d][1,4]ベンゾジアゼピン-6(5H)-オンペルサールセレナールトッカータセレナル【日本】オキサゾラム (JP17)13-クロロ-4-メチル-2-フェニル-3-オキサ-6,9-ジアザトリシクロ[8.4.0.02,6]テトラデカ-1(14),10,12-トリエン-8-オンNebusnToccataSerenal (Japanese)o-2-methyl-11b-phenyl-OXAZOLAM METHANOL SOLUTION
10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenylbenzo(6,7)(1,4)diazepino(5,4-b) oxazol-6-one13-chloro-4-methyl-2-phenyl-3-oxa-6,9-diazatricyclo(8.4.0.0^(2,6))tetradeca-1(10),11,13-trien-8-one246-032-0SerenalSerenal [Japanese]10-Chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one10-Chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2-d][1,4]benzodiazepin-6(5H)-oneBenzo(6,7)-1,4-diazepino-(5,4-b)-oxazol-6-one, 10-chloro-2,3,5,6,7,11b-hexahydro-2-methyl-11b-phenyl-

データベース識別子

CAS
24143-17-7
PubChem CID
4617
DTXSID
DTXSID5023401
ChEMBL
CHEMBL2104805
ChEBI
CHEBI:31944
UNII
1V2WI2NA1C
EC Number
246-032-0
Nikkaji
J3.472J

物性

構造計算による物性

XLogP
3
極性表面積
41.6 Ų
水素結合供与体数
1
水素結合受容体数
3
回転可能結合数
1
重原子数
23

実験および物理化学的性質

Kovats Retention Index2564;2569;2586;2596;2590

物理化学的性質

融点
187 °C · 187°C
沸点
495.8 · 495.8±45.0 °C(Predicted)
比重(密度)
1.2065 · 1.2065 (rough estimate)
屈折率
1.54 · 1.5400 (estimate)
闪点
11 °C · 11 °C
貯蔵温度
2 · 2-8°C

安全と法規制

GHS分類

GHS Classification · 5 件

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral];H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H331 (100%): Toxic if inhaled [Danger Acute toxicity, inhalation]

P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

危険有害性情報

Regulatory InformationDEA schedule IV controlled substance
Hazard Classes and CategoriesAcute Tox. 3 (100%);Skin Irrit. 2 (100%);Eye Irrit. 2 (100%);Acute Tox. 3 (100%)

毒性情報

Treatment · 1 件

General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

Toxicity Summary · 1 件

Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

法規制情報

Regulatory InformationDEA schedule IV controlled substance

安全データ

毒性
LD50 orl-mus: 5200 mg/kg NYKZAU 66,107,70
risk_code
11-23/24/25-39/23/24/25-36/38-23/25
hazard_code
F,T
safety_code
16-36/37-45-24
DEA Controlled Substances
CSCN: 2839CSA SCH: Schedule IVNARC: No

化学と産業

応用分野 · 4 件

解説オキサゾラム.N-(2-ベンゾイル-4-クロロフェニル)ブロモアセトアミドと1-アミノ-2-プロパノールとを加熱反応させると得られる.白色の結晶性粉末.融点約187 ℃.酢酸に易溶,1,4-ジオキサン,ジクロロメタンに可溶,エタノール,エーテルに難溶,水に不溶.トランキライザーとして用いられる.LD50 5200 mg/kg(マウス,経口).

用途ベンゾジアゼピン系化合物で す。GABA受容体に作用し、中枢神経抑制作 用を示します。作用時間は、長時間型とされ ています。

用途ベンゾジアゼピン系化合物で す。GABA 受容体に作用し、中枢神経抑制作 用を示します。作用時間は、長時間型とされ ています。

使用A psychotropic agent with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is a precursor to the active substance Desmethyldiazepam (D291595).

関連反応

7 件

関連ノート

読み込み中…